Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

NCT00001830 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

110

Enrollment

NIH

Sponsor class

Conditions

Chronic Lymphocytic Leukemia
Graft vs Host Disease
Hodgkin's Disease
Multiple Myeloma
Non Hodgkin's Lymphoma

Interventions

DRUG: Th2 cells in allo HSCTT
DRUG: Th2 Cells

Sponsor

National Cancer Institute (NCI)